Marpai (MRAI) Competitors $1.39 +0.04 (+2.96%) As of 06/11/2025 02:45 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock MRAI vs. NAKA, KDLY, ATPC, BMGL, SERA, BDSX, OPGN, PIII, BNR, and CCMShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Kindly MD (NAKA), Kindly MD (KDLY), Agape ATP (ATPC), Basel Medical Group (BMGL), Sera Prognostics (SERA), Biodesix (BDSX), OpGen (OPGN), P3 Health Partners (PIII), Burning Rock Biotech (BNR), and Concord Medical Services (CCM). These companies are all part of the "healthcare" industry. Marpai vs. Its Competitors Kindly MD Kindly MD Agape ATP Basel Medical Group Sera Prognostics Biodesix OpGen P3 Health Partners Burning Rock Biotech Concord Medical Services Marpai (NASDAQ:MRAI) and Kindly MD (NASDAQ:NAKA) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, community ranking, dividends, profitability, earnings, valuation and media sentiment. Which has better earnings and valuation, MRAI or NAKA? Kindly MD has lower revenue, but higher earnings than Marpai. Kindly MD is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$34.87M0.63-$28.75M-$1.82-0.76Kindly MD$2.47M41.42-$4.64M-$0.77-22.04 Is MRAI or NAKA more profitable? Kindly MD has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Company Net Margins Return on Equity Return on Assets Marpai-85.70% N/A -100.23% Kindly MD N/A N/A N/A Do institutionals & insiders have more ownership in MRAI or NAKA? 49.8% of Marpai shares are held by institutional investors. 61.3% of Marpai shares are held by insiders. Comparatively, 50.5% of Kindly MD shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community believe in MRAI or NAKA? Marpai received 2 more outperform votes than Kindly MD when rated by MarketBeat users. CompanyUnderperformOutperformMarpaiOutperform Votes266.67% Underperform Votes133.33% Kindly MDN/AN/A Does the media prefer MRAI or NAKA? In the previous week, Marpai's average media sentiment score of 0.00 equaled Kindly MD'saverage media sentiment score. Company Overall Sentiment Marpai Neutral Kindly MD Neutral SummaryMarpai and Kindly MD tied by winning 5 of the 10 factors compared between the two stocks. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$21.84M$2.01B$7.88B$8.62BDividend YieldN/A7.21%2.60%4.18%P/E Ratio-0.5316.1934.1519.97Price / Sales0.634.52321.83157.64Price / CashN/A9.3230.9334.64Price / Book-0.813.965.444.69Net Income-$28.75M$87.49M$195.24M$248.14M7 Day Performance10.32%3.88%2.13%2.39%1 Month Performance3.73%-1.63%3.25%6.06%1 Year Performance59.31%-16.36%23.83%13.57% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$1.39+3.0%N/A+63.5%$21.84M$34.87M-0.53150NAKAKindly MDN/A$11.60-13.1%N/AN/A$80.50M$2.47M-15.06N/AGap DownKDLYKindly MD0.626 of 5 stars$13.35-15.9%N/A+314.3%$80.39M$2.47M-17.34N/AATPCAgape ATP1.0455 of 5 stars$1.57+4.7%N/A-67.0%$78.51M$1.29M-2.1540Positive NewsBMGLBasel Medical GroupN/A$4.09-7.3%N/AN/A$75.48M$10.05M0.0036Positive NewsGap DownSERASera Prognostics0.634 of 5 stars$1.49-0.7%N/A-82.0%$56.13M$115K-1.51120News CoverageHigh Trading VolumeBDSXBiodesix3.4879 of 5 stars$0.33+13.9%$1.75+430.3%-79.4%$48.37M$74.46M-0.85220Short Interest ↑Gap DownHigh Trading VolumeOPGNOpGenN/A$4.70+0.2%N/A+93.8%$47.32M$2.67M0.00100Positive NewsShort Interest ↓Gap DownPIIIP3 Health Partners2.4197 of 5 stars$6.35-3.2%$16.25+155.9%-79.3%$45.64M$1.49B-7.56500Gap DownBNRBurning Rock Biotech0.727 of 5 stars$3.24+7.3%N/A-61.4%$34.87M$515.82M-1.081,390News CoverageEarnings ReportHigh Trading VolumeCCMConcord Medical Services1.4294 of 5 stars$6.93-2.5%N/A-2.1%$30.07M$383.96M0.00970Short Interest ↓ Related Companies and Tools Related Companies Kindly MD Competitors Kindly MD Competitors Agape ATP Competitors Basel Medical Group Competitors Sera Prognostics Competitors Biodesix Competitors OpGen Competitors P3 Health Partners Competitors Burning Rock Biotech Competitors Concord Medical Services Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRAI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRAI Stock Free MRAI Stock Alerts